Cleared Traditional

Elexir

K211380 · Nu Eyne Co., Ltd. · Neurology
Jul 2021
Decision
87d
Days
Class 2
Risk

About This 510(k) Submission

K211380 is an FDA 510(k) clearance for the Elexir, a Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (Class II — Special Controls, product code PCC), submitted by Nu Eyne Co., Ltd. (Seoul, KR). The FDA issued a Cleared decision on July 30, 2021, 87 days after receiving the submission on May 4, 2021. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5891.

Submission Details

510(k) Number K211380 FDA.gov
FDA Decision Cleared SESE
Date Received May 04, 2021
Decision Date July 30, 2021
Days to Decision 87 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code PCC — Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
Device Class Class II — Special Controls
CFR Regulation 21 CFR 882.5891
Definition Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin.

Similar Devices — PCC Stimulator, Nerve, Electrical, Transcutaneous, For Migraine

All 16
ELEXIR 2.0 (ALLIVE3)
K242719 · Nu Eyne Co., Ltd. · Nov 2024
CEFALY Connected - OTC, CEFALY Connected - Rx
K234029 · Cefaly Technology · Jul 2024
DOOPANG
K232749 · Ybrain, Inc. · Jun 2024
Milieve (YPS-301BD)
K233751 · Soterix Medical, Inc. · Jun 2024
TENS device-HeadaTerm 2 (Model: YF-HT2)
K230782 · Wat Medical Technology, Inc. · Feb 2024
Cefaly Dual Enhanced with RFID - OTC, Cefaly Dual Enhanced with RFID - Rx, Cefaly Dual Connected - OTC, Cefaly Dual Connected - Rx
K212071 · Cefaly Technology · Dec 2022